Literature DB >> 9203693

The eradication of poliomyelitis in Egypt: critical factors affecting progress to date.

R B Aylward1, E Mansour, A O El Said, A Haridi, A Abu El Kheir, A Hassan.   

Abstract

Poliomyelitis eradication activities in Egypt were reviewed to identify the critical factors for the progress seen by 1995 and to highlight problems that could be avoided in other countries in which poliomyelitis is endemic. National immunization and surveillance data demonstrate that the combination of high routine immunization coverage (>85%) with oral polio vaccine combined with two properly conducted rounds of national immunization days (NIDs) resulted in a 75% reduction in reported polio cases between 1992 and 1993. Available data suggest that earlier control strategies, such as single-round NIDs in 1990 and 1991, the administration of inactivated poliovirus vaccine (IPV) at 2 months of age in 1992-1993, and the use of "mop-up" campaigns while wild poliovirus was still widespread, did not contribute substantially to the recent decline in cases. Proper implementation of the World Health Organization's recommended strategies can eliminate wild poliovirus circulation in the large, densely populated tropical countries in which poliomyelitis remains endemic.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203693     DOI: 10.1093/infdis/175.supplement_1.s56

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Serum antibodies to polioviruses in Alexandria, Egypt.

Authors:  R Gabrieli; M Divizia; E El Ghazzawi; O A Kader; Z El Gawhary; E Renganathan; A Panà
Journal:  Eur J Epidemiol       Date:  1999-03       Impact factor: 8.082

2.  Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority.

Authors:  Y Manor; R Handsher; T Halmut; M Neuman; A Bobrov; H Rudich; A Vonsover; L Shulman; O Kew; E Mendelson
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

3.  Estimating the extent of vaccine-derived poliovirus infection.

Authors:  Alison Wringe; Paul E M Fine; Roland W Sutter; Olen M Kew
Journal:  PLoS One       Date:  2008-10-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.